David Haile, MD
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About David Haile, MD
David Haile, MD, is a professor in the Division of Hematology and Oncology at The University of Texas Health Science Center at San Antonio. He is a board-certified and fellowship-trained hematologist-oncologist. He specializes in stem cell transplantation and treating both benign blood disorders and blood cancers, including acute myeloid leukemia, myeloproliferative neoplasms, myelodysplastic syndrome and acute lymphoblastic leukemia.
Haile served as a physician from 1994 to 2022 at Audie Murphy Veterans Administration (VA) Hospital and was appointed the bone marrow transplant program director in 2015. While at the VA, Haile held multiple professorships in the Division of Hematology and Oncology at UT Health San Antonio until 2022.
Gender
- Male
Languages Spoken
- English
- Amharic
-
Credentials
Credentials
Positions
- Professor, Division of Hematology and Oncology, University of Texas Health Science Center San Antonio
Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Hematology
Education
- Medical School: Johns Hopkins University School of Medicine, Baltimore, Maryland
- Residency: Internal Medicine, Beth Israel Deaconess Medical Center, Havard Medical School, Boston, Massachusetts
- Fellowship: Hematology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
- Fellowship: Research, Cell Biology and Metabolism, National Institute of Child Health and Human Development, Bethesda, Maryland
- Undergraduate: Chemistry, Johns Hopkins University, Baltimore, Maryland
- Locations & Contact
-
Research & Publications
Research & Publications
Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
Toro JJ, Gushiken FC, Schneider D, Lee S, Haile DJ, Freytes CO.
Hematopoietic progenitor cell transplantation toxicities in multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw: a longitudinal cohort study
Varadarajan P, Toro JJ, Lee S, Schneider D, Neumon B, Frye B, Craig RM, Haile DJ, Freytes CO.
Deficiency in the divalent metal transporter 1 increases bleomycin-induced lung injury
Yang F, Stonehuerner JG, Richards JH, Nguyen NB, Callaghan KD, Haile DJ, Ghio AJ.
View All Publications - David J. Haile, MD
-
Clinical Trials
Clinical Trials
No Clinical Trials